T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$2.49B |
| 2 |
Apple
AAPL
|
+$1.65B |
| 3 |
Sherwin-Williams
SHW
|
+$1.5B |
| 4 |
Kenvue
KVUE
|
+$1.4B |
| 5 |
HubSpot
HUBS
|
+$1.4B |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$4.49B |
| 2 |
Lam Research
LRCX
|
+$1.45B |
| 3 |
Applied Materials
AMAT
|
+$1.31B |
| 4 |
Fortinet
FTNT
|
+$1.31B |
| 5 |
GE Vernova
GEV
|
+$1.19B |
Sector Composition
| 1 | Technology | 32.36% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LENZ
1126
LENZ Therapeutics
LENZ
$1.16B
| $10.7M | ﹤0.01% |
+448,631
| New | +$10.7M |
|
1127
HEICO Class A
HEI.A
$35.3B
| $10.6M | ﹤0.01% |
51,873
+3,590
| +7% | +$732K |
|
1128
CONMED
CNMD
$1.65B
| $10.5M | ﹤0.01% |
146,410
-34,600
| -19% | -$2.49M |
|
1129
Marathon Digital Holdings
MARA
$6.05B
| $10.5M | ﹤0.01% |
648,908
+499,695
| +335% | +$8.11M |
|
1130
Tencent Music
TME
$38.5B
| $10.5M | ﹤0.01% |
868,081
-519,568
| -37% | -$6.26M |
|
1131
Check Point Software Technologies
CHKP
$21B
| $10.5M | ﹤0.01% |
54,241
+32,745
| +152% | +$6.31M |
|
1132
Petrobras Class A
PBR.A
$75.5B
| $10.4M | ﹤0.01% |
788,153
| – | – |
|
1133
Fortune Brands Innovations
FBIN
$7.21B
| $10.3M | ﹤0.01% |
115,474
-82,037
| -42% | -$7.35M |
|
1134
Texas Pacific Land
TPL
$21.6B
| $10.3M | ﹤0.01% |
11,600
+758
| +7% | +$671K |
|
1135
Bloomin' Brands
BLMN
$577M
| $10.2M | ﹤0.01% |
616,798
-316,820
| -34% | -$5.24M |
|
1136
Acadia Pharmaceuticals
ACAD
$3.97B
| $10.2M | ﹤0.01% |
659,964
-260,122
| -28% | -$4M |
|
1137
Lyell Immunopharma
LYEL
$252M
| $10.1M | ﹤0.01% |
367,614
-26,004
| -7% | -$718K |
|
1138
Vertex
VERX
$3.84B
| $9.82M | ﹤0.01% |
255,050
-1,800
| -0.7% | -$69.3K |
|
1139
Pegasystems
PEGA
$9.92B
| $9.58M | ﹤0.01% |
262,096
+208,190
| +386% | +$7.61M |
|
1140
Sony
SONY
$175B
| $9.51M | ﹤0.01% |
+492,350
| New | +$9.51M |
|
1141
Full Truck Alliance
YMM
$14.2B
| $9.43M | ﹤0.01% |
1,046,489
-46,691
| -4% | -$421K |
|
1142
NorthWestern Energy
NWE
$3.5B
| $9.42M | ﹤0.01% |
164,529
+19,574
| +14% | +$1.12M |
|
|
BIOA
1143
BioAge Labs, Inc. Common Stock
BIOA
$173M
| $9.36M | ﹤0.01% |
+449,837
| New | +$9.36M |
|
1144
Varonis Systems
VRNS
$6.33B
| $9.3M | ﹤0.01% |
164,661
+96,084
| +140% | +$5.43M |
|
1145
Masimo
MASI
$7.99B
| $9.3M | ﹤0.01% |
69,716
+1,427
| +2% | +$190K |
|
1146
Alto Neuroscience
ANRO
$106M
| $9.25M | ﹤0.01% |
808,504
+162,672
| +25% | +$1.86M |
|
1147
Bio-Rad Laboratories Class A
BIO
$7.6B
| $9.24M | ﹤0.01% |
27,620
-17,730
| -39% | -$5.93M |
|
1148
National Grid
NGG
$70.9B
| $9.21M | ﹤0.01% |
+138,339
| New | +$9.21M |
|
1149
Graco
GGG
$14.1B
| $9.15M | ﹤0.01% |
104,511
+4,470
| +4% | +$391K |
|
|
WBA
1150
DELISTED
Walgreens Boots Alliance
WBA
| $9.13M | ﹤0.01% |
1,019,252
+13,720
| +1% | +$123K |
|